Evidence map›Paper›PMID 41214784›Full record

ArticleTrials2025

Bayesian enrollment modeling for several emergency medicine clinical trials.

Jonathan Beall, Sharon D Yeatts, Robert Silbergleit, Lori Shutter, Frederick Korley, Byron Gajewski

Registry-linked trialAbstract read
In one paragraph

Article in Trials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02407028 (Hyperbaric Oxygen Brain Injury Treatment), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02407028 phase2recruitingnot on this map

Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial

TypeinterventionalSponsorGaylan RockswoldRan2018 to 2029Enrolled200ConditionsTraumatic Brain InjuryArmsHyperbaric oxygen (1.5 ATA, no NBH), Hyperbaric oxygen (2.0 ATA, no NBH), Hyperbaric oxygen (2.5 ATA, no NBH), Hyperbaric oxygen (1.5 ATA + NBH), Hyperbaric oxygen (2.0 ATA + NBH)
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jonathan Beall *Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA. bealljo@musc.edu.ORCID http://orcid.org/0000-0003-2135-2606
Sharon D YeattsDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
Robert SilbergleitDepartment of Emergency Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Lori ShutterDepartment of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Frederick KorleyDepartment of Emergency Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Byron Gajewski *Department of Biostatistics and Data Science, Kansas University Medical Center, Kansas City, Kansas, USA.

Funding

Brain Oxygen Optimization in Severe Traumatic Brain Injury - Phase 3 (BOOST-3)U01NS099046 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Ramon Diaz-Arrastia, Lori Shutter · 2018 to 2026
$35.7M
1/2 ICECAP: Influence of Cooling duration on Efficacy in Cardiac Arrest PatientsUH3HL145269 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GEOCADIN, ROMERGRYKO, MEURER, WILLIAM JOSEPH · 2020 to 2024
$21.4M
Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial - CCCU01NS095926 · NINDS · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI Byron J. Gajewski, Frederick Kofi Korley · 2017 to 2026
$12.3M
Hyperbaric Oxygen BrainInjury Treatment (HOBIT) Trial-SDMC Supplement FITBIRU01NS095814 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MARTIN, RENEE HEBERT · 2017 to 2022
$2.3M
NHLBI Division of Intramural Research U24HL145272NHLBI NIH HHS UH3HL145269NINDS, NHLBI, NCATS U24NS100659NINDS NIH HHS U01NS095814NINDS NIH HHS U01NS095926NINDS NIH HHS U01 NS099046NINDS NIH HHS U01NS099046
6 · The paper itself

Abstract

backgroundAccrual of participants into clinical trials is a fundamental and important aspect for the management of trial progress. Monitoring of trial accrual often provides insight into the potential timing of key study events, such as interim analysis, as well as the feasibility of the overall trial to enroll the projected sample size in the original estimated timeline.

methodsA Bayesian first order simple dynamic linear model with weakly informative priors is utilized to characterize enrollment rates temporally within pre-defined time windows (quarterly) for the duration of a trial.

resultsApplication of the model to three ongoing clinical trials demonstrates the utility of the model to characterize the observed accrual patterns. Additionally, the applications demonstrate the flexibility of the model to react to variable accrual patterns without overreacting to the variability of accrual within a trial due to expected causes, such as seasonal variability in disease incidence, or unexpected causes, such as a global pandemic.

conclusionsMuch statistical literature has been dedicated to predicting when key study events are likely to occur by utilizing current estimated rates of participant accrual; however, study teams, sponsors, and funding agencies have interest in the previous trends in participant accrual. This work presents an addition to the literature which allows parties interested in assessing trial progress to do so by providing a flexible framework for the standardized characterization of trial accrual which is not overly sensitive to the expected variability of trial accrual.

Indexed as

Clinical Trials as TopicEmergency MedicinePatient SelectionResearch DesignBayes TheoremHumansSample SizeTime FactorsBayesianClinical trialEnrollment modelingNDLM

Identifiers

PMID41214784
PMCPMC12599014

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.